Skip to content

Hearing · house

“Stifling Innovation: Examining the Impacts of Regulatory Burdens on Small Businesses in Healthcare”

2024-05-08 · 14:00

Source status: Scheduled

Committee

Location

2360, Rayburn House Office Building

Witnesses

  1. Mr. William Newell, J.D

    Chief Executive Officer, Sutro Biopharma, Inc.

  2. Dr. David Eagle, MD

    Medical Oncologist & Chair of Legislative Affairs and Patient Advocacy, New York Cancer & Blood Specialists

  3. Dr. Brian Miller, MD, MBA, MPH

    Assistant Professor of Medicine, Johns Hopkins University School of Medicine

  4. Dr. Diana Zuckerman

    President, National Center for Health Research

Official published hearing

Congress.gov explicitly associates this publication with this proceeding.

  • H.Hrg.118-50

    STIFLING INNOVATION: EXAMINING THE IMPACTS OF REGULATORY BURDENS ON SMALL BUSINESSES IN HEALTHCARE

    No. 50 · 2024-05-08 · GovInfo record 2024-10-12

Documents

Source: https://api.congress.gov/v3/committee-meeting/118/house/117237